` Comparison: VPA1, PNEXF - Alpha Spread

A
VPA1
vs
PNEXF

Over the past 12 months, VPA1 has underperformed PNEXF, delivering a return of 0% compared to the PNEXF's 0% growth.

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
VPA1
PNEXF
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Valuation
Growth
Profitability
Solvency
Comparing Valuation
Running a multi-layered valuation analysis to compare how attractive each stock is.
Comparing Growth
Financial growth, forecasts, volatility, and historical drawdowns.
Comparing Profitability
Margins, returns on capital, and the consistency of profitability.
Comparing Solvency
Debt levels, liquidity, interest coverage, and bankruptcy risk.
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

A
VPA1 Intrinsic Value
Not Available
PNEXF Intrinsic Value
Not Available
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
A
Aveo Pharmaceuticals Inc
F:VPA1
13.77 EUR
Pharnext SCA
OTC:PNEXF
999 999.9999 USD
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
VPA1, PNEXF

VPA1
PNEXF
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
A
Aveo Pharmaceuticals Inc
Revenue
Pharnext SCA
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
VPA1, PNEXF

VPA1
PNEXF
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
A
Aveo Pharmaceuticals Inc
F:VPA1
Pharnext SCA
OTC:PNEXF
What is Free Cash Flow?

Gross Margin

VPA1
87.8%
PNEXF
0%
LTM 3Y Avg 5Y Avg 10Y Avg
A
Aveo Pharmaceuticals Inc
Pharnext SCA

Operating Margin

VPA1
-26%
PNEXF
-17 526.7%
LTM 3Y Avg 5Y Avg 10Y Avg
A
Aveo Pharmaceuticals Inc
Pharnext SCA

Net Margin

VPA1
-30.8%
PNEXF
-21 040%
LTM 3Y Avg 5Y Avg 10Y Avg
A
Aveo Pharmaceuticals Inc
Pharnext SCA

FCF Margin

VPA1
-24%
PNEXF
-15 953.3%
LTM 3Y Avg 5Y Avg 10Y Avg
A
Aveo Pharmaceuticals Inc
Pharnext SCA

ROE

VPA1
-72.5%
PNEXF
114.6%
LTM 3Y Avg 5Y Avg 10Y Avg
A
Aveo Pharmaceuticals Inc
Pharnext SCA

ROA

VPA1
-27.6%
PNEXF
-391.1%
LTM 3Y Avg 5Y Avg 10Y Avg
A
Aveo Pharmaceuticals Inc
Pharnext SCA

ROIC

VPA1
-169.3%
PNEXF
3 092.9%
LTM 3Y Avg 5Y Avg 10Y Avg
A
Aveo Pharmaceuticals Inc
Pharnext SCA

ROCE

VPA1
-33.7%
PNEXF
275.4%
LTM 3Y Avg 5Y Avg 10Y Avg
A
Aveo Pharmaceuticals Inc
Pharnext SCA

Solvency Comparison

Balance Sheet Comparison

Stocks Performance

Stocks Performance
VPA1, PNEXF

Loading

Performance Gap
VPA1, PNEXF

Loading
VPA1
PNEXF
Difference
www.alphaspread.com

Performance By Year
VPA1, PNEXF

Loading
VPA1
PNEXF
Add Stock
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare VPA1 to other stocks
Unlock Full Access to Alpha Spread
Create Free Account